Drugs / NTS071
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT07060989 | Aug 2025 → Dec 2028 expected | cancer | Nutshell Therapeutics (Shanghai) Co., LTD. | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | NTS071 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07060989 ↗ |
| Route | Oral | “Oral administration” NCT07060989 ↗ |